Released Aug 13, 2015, after the close
10-Q filed Aug 13, 2015, 44 days after period end · 0001144204-15-048978
Q2 2015 · 10-Q
Revenue—
Net Income-$6.94M-$6.94M N/M vs Q2 2014N/M vs Q1 2015
EPS Diluted-$0.41-$0.41 N/M vs Q2 2014N/M vs Q1 2015
Operating Income-$7,153,905N/M
Operating Cash Flowderived-$4,382,654N/M
Free Cash Flowderived-$4,399,934N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2015 | Q2 2014 | Q2 2013 | Q2 2012 |
|---|---|---|---|---|
| Net Income | -$6.94M | -$2.47M | -$4.75M | -$7.47M |
| EPS Diluted | -$0.41 | -$0.52 | -$1.20 | -$0.59 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR